IL33 and central nervous system cancer: De Boeck et al. have shown that IL-33 derived from glioma cells and a subset of Iba1+ microglia increases phosphorylated STAT3 (p-STAT3), potentially upregulating the expression of downstream LIF and IL-6 in both cell types [59,60].